Physician profile
John Arthur Spratt
NPI 1356301691
$6,376.33
in general payments reported to CMS, 2019-2025
16 companies · $846 in 2025
The $846 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $1,471 · 2021: $1,951 · 2022: $483 · 2023: $269 · 2024: $933 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,617 · Travel and Lodging: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,616.53 |
| Travel and Lodging | $432.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,999.22 | 2020-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Intuitive Surgical, INC. | $1,736.49 | 2021-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $477.68 | 2021-2025 | Corevalve Evolut R, Penditure |
| Abbott Laboratories | $403.08 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $389.89 | 2019-2025 | Gore Viabahn Endoprosthesis |
| Bolton Medical INC | $285.58 | 2025 | Thoraflex Hybrid, Treo Abdominal Stent-Graft System |
| Hemosonics LLC | $236.47 | 2019-2021 | |
| Sanara Medtech INC. | $179.40 | 2025 | Celleraterx |
| Edwards Lifesciences Corporation | $157.78 | 2019-2022 | |
| Cook Incorporated | $140.85 | 2020 | |
| Medtronic Vascular, INC. | $139.10 | 2020 | |
| Cvrx, INC. | $125.02 | 2024 | Barostim Neo System |
| Getinge USA Sales, LLC | $36.78 | 2020 | |
| Pfizer INC. | $24.09 | 2025 | |
| Livanova USA, INC. | $24.03 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.87 | 2024 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Spratt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.